Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

finance.yahoo.com · 2026-08-29

Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.